Healthcare -
Biotechnology - NASDAQ - US
$ 11.7775
-1.36 %
$ 443 M
Market Cap
7.01
P/E
TRDA - GROSS PROFIT
Gross Profit TRDA - Entrada Therapeutics, Inc.
29.1 M
LAST VALUE
429.89%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR